{"nct_id":"NCT03820986","title":"Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2019-03-12","start_date_type":"ACTUAL","primary_completion_date":"2023-01-18","primary_completion_date_type":"ACTUAL","completion_date":"2024-11-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}